Top compounds associated with response to RNF165


Feature Type Standardized
Nominal ANOVA
mRNA PD318088 CTRPv2 pan-cancer AAC -0.17 6e-05
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.17 6e-05
mRNA barasertib CTRPv2 pan-cancer AAC 0.15 6e-05
mRNA RG-108 CTRPv2 pan-cancer AAC 0.17 7e-05
mRNA SMER-3 CTRPv2 pan-cancer AAC 0.17 7e-05
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.17 9e-05
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC 0.12 0.0001
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.15 0.0002
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 0.0002
Download CSV